Elevated expression of pp60c-src in low grade human bladder carcinoma.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer Research

• Publication date

  1992-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1371716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of p53 gene mutations in bladder cancers and urine samples.

  1991cited by this paper
• Altered tyrosine 527 phosphorylation and mitotic activation of p60c-src

  1991cited by this paper
• Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src

  1991cited by this paper
• Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

  1990cited by this paper
• Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells.

  1990cited by this paper
• Early activation of endogenous pp60src kinase activity during neuronal differentiation of cultured human neuroblastoma cells

  1990cited by this paper
• c-Ha-ras-I oncogene-induced differentiation and natural killer cell resistance in a human colorectal carcinoma cell line.

  1990cited by this paper
• Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma.

  1990cited by this paper
• pp60c-src activation in human colon carcinoma.

  1989cited by this paper
• Oncogenes, growth factors, and signal transduction.

  1989cited by this paper
• Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes.

  1989cited by this paper
• Preferential and novel activation of H-ras in human bladder carcinomas.

  1988cited by this paper
• Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes

  1988cited by this paper
• pp60c-src expression in the developing rat brain.

  1988cited by this paper
• Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.

  1988cited by this paper
• Preferential and novel activation of H-ras in human bladder carcinomas.

  1988cited by this paper
• The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus

  1988cited by this paper
• Characterization of the altered form of the c-src gene product in neuronal cells.

  1987cited by this paper
• An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal.

  1987cited by this paper
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.

  1987cited by this paper
• Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation

  1987cited by this paper
• Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.

  1987cited by this paper
• Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

  1987cited by this paper
• Alterations in pp60c-src accompany differentiation of neurons from rat embryo striatum

  1987cited by this paper
• Characterization of human uroepithelial cells immortalized in vitro by simian virus 40.

  1987cited by this paper
• Activation of pp60c-src protein kinase activity in human colon carcinoma.

  1987cited by this paper
• Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src.

  1987cited by this paper
• Activation of the transforming potential of p60c-src by a single amino acid change.

  1986cited by this paper
• Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen

  1986cited by this paper
• Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein

  1986cited by this paper
• Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines.

  1986cited by this paper
• Tyr527 is phosphorylated in pp60c-src: implications for regulation.

  1986cited by this paper
• Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues.

  1986cited by this paper
• Activation of the pp60c‐src kinase by middle T antigen binding or by dephosphorylation.

  1985cited by this paper
• Neurones express high levels of a structurally modified, activated form of pp60c-src

  1985cited by this paper
• Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors.

  1985cited by this paper
• Increased pp60c-src tyrosyl kinase activity in human neuroblastomas is associated with amino-terminal tyrosine phosphorylation of the src gene product.

  1985cited by this paper
• Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation.

  1985cited by this paper
• Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells

  1985cited by this paper
• A cell line from an anaplastic transitional cell carcinoma of human urinary bladder.

  1977cited by this paper

• Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem‐immunoreceptor tyrosine‐based activation motif

  2024cites this paper
• Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by network pharmacology and molecular docking

  2024cites this paper
• CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma

  2023cites this paper
• Genistein Suppresses v-Src-Driven Proliferative Activity by Arresting the Cell-Cycle at G2/M through Increasing p21 Level in Src-Activated Human Gallbladder Carcinoma cells

  2020cites this paper
• Interaction of BIR2/3 of XIAP with E2F1/Sp1 Activates MMP2 and Bladder Cancer Invasion by Inhibiting Src Translation

  2018cites this paper
• Galectin-1 promotes the invasion of bladder cancer urothelia through their matrix milieu

  2018cites this paper
• Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue

  2018cites this paper
• Pathophysiology of Bladder Cancer

  2018cites this paper
• Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.

  2016cites this paper
• The role of Src kinase in renal cell carcinoma

  2014cites this paper
• Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

  2014cites this paper
• Decreased expression of c-Src in human transitional cell carcinoma

  2014cites this paper
• The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder

  2012cites this paper
• Clinical significance of Src expression and activity in human neoplasia.

  2012cites this paper
• Expression and prognostic significance of Src family members in renal clear cell carcinoma

  2012cites this paper
• The faces and friends of RhoGDI2

  2012cites this paper
• Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer.

  2011cites this paper
• Curcumin Modulates MicroRNA-203–Mediated Regulation of the Src-Akt Axis in Bladder Cancer

  2011cites this paper
• Dasatinib Is Preclinically Active against Src-Overexpressing Human Transitional Cell Carcinoma of the Urothelium with Activated Src Signaling

  2010cites this paper
• Pathways of metastasis suppression in bladder cancer

  2009cites this paper
• Cyclic peptide substrates of pp60c-src. Synthesis and evaluation.

  2009cites this paper
• Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function

  2009cites this paper
• Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer

  2007cites this paper
• Src, chemoresistance and epithelial to mesenchymal transition: are they related?

  2007cites this paper
• Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders.

  2007cites this paper
• SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.

  2007cites this paper
• The Src signaling pathway: a potential target in melanoma and other malignancies

  2007cites this paper
• Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors.

  2006cites this paper
• Potent Pseudosubstrate-basedPeptide Inhibitors for p 6 O

  2006cites this paper
• Expression of cSrc and comparison of cytologic features in cherubism , central giant cell granuloma and giant cell tumors

  2006cites this paper
• The src‐family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt

  2005cites this paper
• Structure-activity relationship of a novel peptide substrate for p60c-src protein tyrosine kinase

  2004cites this paper
• Basis and importance of Src as a target in cancer.

  2004cites this paper
• Src family kinases in tumor progression and metastasis

  2003cites this paper
• Development and characterization of potent and specific peptide inhibitors of p60c-src protein tyrosine kinase using pseudosubstrate-based inhibitor design approach.

  2003cites this paper
• Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2

  2002cites this paper
• Lauryl Gallate Inhibits the Activity of Protein Tyrosine Kinase c-Src Purified from Human Platelets

  2001cites this paper
• Hsp27-induced MMP-9 expression is influenced by the Src tyrosine protein kinase yes.

  2001cites this paper
• The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic value

  2001cites this paper
• Deregulation of the cytoplasmic tyrosine kinase cSrc in the absence of a truncating mutation at codon 531 in human bladder carcinoma.

  2000cites this paper
• Suppression of malignant growth potentials of v‐Src‐transformed human gallbladder epithelial cells by adenovirus‐mediated dominant negative h‐ras

  2000cites this paper
• The expression of c-src gene in the carcinogenesis process of human cardia adenocarcinoma.

  1999cites this paper
• Cyclic peptides as probes of the substrate binding site of the cytosolic tyrosine kinase, pp60c-src.

  1998cites this paper
• Molecular Genetics in Carcinoma of the Bladder

  1998cites this paper
• Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells

  1998cites this paper
• Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and osteolytic bone disease

  1998cites this paper
• Potent pseudosubstrate-based peptide inhibitors for p60(c-src) protein tyrosine kinase.

  1997cites this paper
• Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio.

  1996cites this paper
• Increased immunoreactivity and protein tyrosine kinase activity of the protooncogene pp60c-src in preneoplastic lesions in rat pancreas.

  1996cites this paper
• c‐Src PROTEIN EXPRESSION IS INCREASED IN HUMAN BREAST CANCER. AN IMMUNOHISTOCHEMICAL AND BIOCHEMICAL ANALYSIS

  1996cites this paper
• Pathology and staging of bladder cancer.

  1996cites this paper
• The focal adhesion kinase.

  1996cites this paper
• Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells.

  1996cites this paper
• Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.

  1996cites this paper
• Development of a selective pseudosubstrate-based peptide inhibitor of pp60c-src protein tyrosine kinase

  1996cites this paper
• Trisomy 20 in a papillary urothelial carcinoma of the ureter.

  1996cites this paper
• Inhibitors of protein tyrosine kinases

  1995cites this paper
• POLYHYDROXYLATED 3-(N-PHENYL) CARBAMOYL-2-IMINOCHROMENE DERIVATIVES AS POTENT INHIBITORS OF TYROSINE KINASE P60C-SRC

  1995cites this paper
• Discovery, development, and testing of substrates and inhibitors of pp60c-SRC

  1995cites this paper
• Identification of efficient pentapeptide substrates for the tyrosine kinase pp60c-src.

  1995cites this paper
• Overexpression of genes in health and sickness. A bird's eye view.

  1995cites this paper
• Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.

  1995cites this paper
• Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors.

  1995cites this paper
• pp60v-src kinase overexpression leads to cellular resistance to the antiproliferative effects of tumor necrosis factor.

  1994cites this paper
• Ha-ras codon 12 mutation in papillary tumors of the urinary-bladder - a retrospective study.

  1994cites this paper
• Activity of pp60c-src in 60 different cell lines derived from human tumors.

  1994cites this paper
• pp60ν‐src kinase overexpression leads to cellular resistance to the antiproliferative effects of tumor necrosis factor

  1994cites this paper
• Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

  1994cites this paper
• Protein tyrosine kinases as therapeutic targets in cancer chemotherapy and recent advances in the development of new inhibitors

  1994cites this paper
• Increased expression of pp60c-src in gastric mucosa of aged rats.

  1994cites this paper
• Enzyme, whole cell and invivo tumor-models to identify and assess inhibitors of pp60(c-SRC).

  1993cites this paper
• Screening of human bladder tumors and urine sediments for the presence of H‐ras mutations

  1993cites this paper
• Molecular events in the initiation and progression of bladder-cancer (review).

  1993cites this paper
• Site-specific differences in pp60c-src activity in human colorectal metastases.

  1993cites this paper
• Chromosome changes in early bladder neoplasms

  1992cites this paper
• Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.

  1992cites this paper